Search results

• 2024

  Chondroitin Sulfate Proteoglycan 4 (CSPG4) as an Emerging Target for Immunotherapy to Treat Melanoma

  Chen, X., Habib, S., Alexandru, M., Chauhan, J., Evan, T., Troka, J. M., Rahimi, A., Esapa, B., Tull, T. J., Ng, W. Z., Fitzpatrick, A., Wu, Y., Geh, J. L. C., Lloyd-Hughes, H., Palhares, L. C. G. F., Adams, R., Bax, H. J., Whittaker, S., Jacków-Malinowska, J. & Karagiannis, S. N., 25 Sept 2024, In: Cancers. 16, 19, 3260.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Proteochondroitin Sulfate 100%
  • Melanoma 100%
  • Therapeutic Procedure 37%
  • Patient 25%
  • Mimotope 16%
• 2023

  Target Antigen Attributes and Their Contributions to Clinically Approved Antibody-Drug Conjugates (ADCs) in Haematopoietic and Solid Cancers

  Esapa, B., Jiang, J., Cheung, A., Chenoweth, A., Thurston, D. E. & Karagiannis, S. N., 19 Mar 2023, In: Cancers. 15, 6, 37 p., 1845.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  File

  • Antibody Drug Conjugate 100%
  32 Citations (Scopus)

  303 Downloads (Pure)